LDL-C goal attainment with the addition of ezetimibe to on-going simvastatin treatment in coronary heart disease patients with hypercholesterolemia - Concepedia

Concepedia

Publication | Closed Access

LDL-C goal attainment with the addition of ezetimibe to on-going simvastatin treatment in coronary heart disease patients with hypercholesterolemia

44

Citations

25

References

2005

Year

C. Brohet, Shmuel Banai, A. Marco Alings, Rachid Massaad, Michael J. Davies, Christopher Allen

Current Medical Research and Opinion

Abstract

Ezetimibe co-administered with on-going simvastatin 10 mg or 20 mg treatment enabled more CHD patients with hypercholesterolemia to attain the LDL-C treatment target of </= 2.60 mmol/L.

References

	Year	Citations

Page 1